Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Idarucizumab for dabigatran overdose
Journal article

Idarucizumab for dabigatran overdose

Abstract

CONTEXT: An overdose of oral anticoagulants represents a challenging scenario for emergency physicians. Dabigatran, an oral direct thrombin inhibitor, is increasingly used in place of warfarin. The lack of an antidote is a concern in patients who overdose on dabigatran, even though the drug can be eliminated with hemodialysis. Idarucizumab is an antibody fragment that binds dabigatran with high affinity. It reverses the anticoagulant effect of …

Authors

Peetermans M; Pollack C; Reilly P; Liesenborghs L; Jacquemin M; Levy JH; Weitz JI; Verhamme P

Journal

Journal of Toxicology Clinical Toxicology, Vol. 54, No. 8, pp. 644–646

Publisher

Taylor & Francis

Publication Date

September 13, 2016

DOI

10.1080/15563650.2016.1187737

ISSN

1556-3650